Found: 133
Select item for more details and to access through your institution.
Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study.
- Published in:
- Diabetologia, 2021, v. 64, n. 5, p. 1066, doi. 10.1007/s00125-021-05392-9
- By:
- Publication type:
- Article
Mitochondria hyperactivity contributes to social behavioral impairments.
- Published in:
- Signal Transduction & Targeted Therapy, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41392-020-00239-y
- By:
- Publication type:
- Article
NLRP3 inflammasome as a novel therapeutic target for Alzheimer's disease.
- Published in:
- Signal Transduction & Targeted Therapy, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41392-020-0145-7
- By:
- Publication type:
- Article
MKP-1 reduces Aβ generation and alleviates cognitive impairments in Alzheimer's disease models.
- Published in:
- Signal Transduction & Targeted Therapy, 2019, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41392-019-0091-4
- By:
- Publication type:
- Article
Overexpression of ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) delays Alzheimer's progression in vivo.
- Published in:
- Scientific Reports, 2014, p. 1, doi. 10.1038/srep07298
- By:
- Publication type:
- Article
Two novel DNA motifs are essential for BACE1 gene transcription.
- Published in:
- Scientific Reports, 2014, p. 1, doi. 10.1038/srep06864
- By:
- Publication type:
- Article
Combination of retagliptin and henagliflozin as add‐on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double‐blind, active‐controlled, phase 3 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 7, p. 2774, doi. 10.1111/dom.15596
- By:
- Publication type:
- Article
Efficacy and safety of janagliflozin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled on diet and exercise: A multicentre, randomized, double‐blind, placebo‐controlled, Phase 3 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1229, doi. 10.1111/dom.14971
- By:
- Publication type:
- Article
Efficacy and safety of janagliflozin as add‐on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin alone: A multicentre, randomized, double‐blind, placebo‐controlled, phase 3 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. 785, doi. 10.1111/dom.14926
- By:
- Publication type:
- Article
Determining the optimal fasting glucose target for patients with type 2 diabetes: Results of the multicentre, open‐label, randomized‐controlled FPG GOAL trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 8, p. 1973, doi. 10.1111/dom.13733
- By:
- Publication type:
- Article
Comparative effectiveness of metformin monotherapy in extended release and immediate release formulations for the treatment of type 2 diabetes in treatment‐naïve Chinese patients: Analysis of results from the CONSENT trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 4, p. 1006, doi. 10.1111/dom.13190
- By:
- Publication type:
- Article
Deficiency of Pdk1 drives heart failure by impairing taurine homeostasis through Slc6a6.
- Published in:
- FASEB Journal, 2023, v. 37, n. 9, p. 1, doi. 10.1096/fj.202300272R
- By:
- Publication type:
- Article
USP25 contributes to defective neurogenesis and cognitive impairments.
- Published in:
- FASEB Journal, 2023, v. 37, n. 6, p. 1, doi. 10.1096/fj.202300057R
- By:
- Publication type:
- Article
Distinct effects of SDC3 and FGFRL1 on selective neurodegeneration in AD and PD.
- Published in:
- FASEB Journal, 2023, v. 37, n. 2, p. 1, doi. 10.1096/fj.202201359R
- By:
- Publication type:
- Article
Preview Abstract Research JUNE 2018 Formaldehyde induces diabetes-associated cognitive impairments.
- Published in:
- FASEB Journal, 2018, v. 32, n. 7, p. 3669, doi. 10.1096/fj.201701239R
- By:
- Publication type:
- Article
Down-regulation of MIF by NFκB under hypoxia accelerated neuronal loss during stroke.
- Published in:
- FASEB Journal, 2014, v. 28, n. 10, p. 4394, doi. 10.1096/fj.14-253625
- By:
- Publication type:
- Article
Regulation of RCAN1 translation and its role in o dative stress-induced apoptosis.
- Published in:
- FASEB Journal, 2013, v. 27, n. 1, p. 208, doi. 10.1096/fj.12-213124
- By:
- Publication type:
- Article
Degradation of regulator of calcineurin 1 (RCAN1) is mediated by both chaperone-mediated autophagy and ubiquitin proteasome pathways.
- Published in:
- FASEB Journal, 2009, v. 23, n. 10, p. 3383, doi. 10.1096/fj.09-134296
- By:
- Publication type:
- Article
Transcriptional regulation of human USP24 gene expression by NF-kappa B.
- Published in:
- Journal of Neurochemistry, 2014, v. 128, n. 6, p. 818, doi. 10.1111/jnc.12626
- By:
- Publication type:
- Article
Targeting nascent soluble Aβ42 for potential Alzheimer drug development.
- Published in:
- Journal of Neurochemistry, 2013, v. 125, n. 3, p. 329, doi. 10.1111/jnc.12156
- By:
- Publication type:
- Article
Hypoxia regulation of ATP13A2 (PARK9) gene transcription.
- Published in:
- Journal of Neurochemistry, 2012, v. 122, n. 2, p. 251, doi. 10.1111/j.1471-4159.2012.07676.x
- By:
- Publication type:
- Article
Control of BACE1 degradation and APP processing by ubiquitin carboxyl-terminal hydrolase L1.
- Published in:
- Journal of Neurochemistry, 2012, v. 120, n. 6, p. 1129, doi. 10.1111/j.1471-4159.2011.07644.x
- By:
- Publication type:
- Article
Regulation of β-site APP-cleaving enzyme 1 gene expression and its role in Alzheimer's Disease.
- Published in:
- Journal of Neurochemistry, 2012, v. 120, p. 62, doi. 10.1111/j.1471-4159.2011.07515.x
- By:
- Publication type:
- Article
Loss of activated CaMKII at the synapse underlies Alzheimer's disease memory loss.
- Published in:
- Journal of Neurochemistry, 2011, v. 119, n. 4, p. 673, doi. 10.1111/j.1471-4159.2011.07473.x
- By:
- Publication type:
- Article
NF-κB signaling inhibits ubiquitin carboxyl-terminal hydrolase L1 gene expression.
- Published in:
- Journal of Neurochemistry, 2011, v. 116, n. 6, p. 1160, doi. 10.1111/j.1471-4159.2011.07172.x
- By:
- Publication type:
- Article
SP1 regulates a human SNAP-25 gene expression.
- Published in:
- Journal of Neurochemistry, 2008, v. 105, n. 2, p. 512, doi. 10.1111/j.1471-4159.2007.05167.x
- By:
- Publication type:
- Article
Degradation of nicastrin involves both proteasome and lysosome.
- Published in:
- Journal of Neurochemistry, 2007, v. 101, n. 4, p. 982, doi. 10.1111/j.1471-4159.2007.04449.x
- By:
- Publication type:
- Article
Ubiquitin–proteasome pathway mediates degradation of APH-1.
- Published in:
- Journal of Neurochemistry, 2006, v. 99, n. 5, p. 1403, doi. 10.1111/j.1471-4159.2006.04184.x
- By:
- Publication type:
- Article
The moderated-mediation role of risk perception and intolerance of uncertainty in the association between residual symptoms and psychological distress: a cross-sectional study after COVID-19 policy lifted in China.
- Published in:
- BMC Psychiatry, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12888-024-05591-9
- By:
- Publication type:
- Article
BACE1 Gene Expression and Protein Degradation.
- Published in:
- Annals of the New York Academy of Sciences, 2004, v. 1035, n. 1, p. 49, doi. 10.1196/annals.1332.004
- By:
- Publication type:
- Article
Contactin-associated protein-like 2 (CNTNAP2) mutations impair the essential α-secretase cleavages, leading to autism-like phenotypes.
- Published in:
- Signal Transduction & Targeted Therapy, 2024, p. 1, doi. 10.1038/s41392-024-01768-6
- By:
- Publication type:
- Article
The role of inflammasomes in human diseases and their potential as therapeutic targets.
- Published in:
- Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-023-01687-y
- By:
- Publication type:
- Article
Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential.
- Published in:
- Translational Neurodegeneration, 2022, v. 11, n. 1, p. 1, doi. 10.1186/s40035-022-00279-0
- By:
- Publication type:
- Article
Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential.
- Published in:
- Translational Neurodegeneration, 2022, v. 11, n. 1, p. 1, doi. 10.1186/s40035-022-00279-0
- By:
- Publication type:
- Article
GPSAdb: a comprehensive web resource for interactive exploration of genetic perturbation RNA-seq datasets.
- Published in:
- Nucleic Acids Research, 2023, v. 51, n. D1, p. D964, doi. 10.1093/nar/gkac1066
- By:
- Publication type:
- Article
Transcriptional activation of USP16 gene expression by NFκB signaling.
- Published in:
- Molecular Brain, 2019, v. 12, n. 1, p. 1, doi. 10.1186/s13041-019-0535-3
- By:
- Publication type:
- Article
Regulation of global gene expression in brain by TMP21.
- Published in:
- Molecular Brain, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13041-019-0460-5
- By:
- Publication type:
- Article
17-OR: Efficacy and Safety of Chiglitazar, a Novel PPARα/γ/d Pan-Agonist, in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Superiority Trial (CMAP).
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-17-OR
- By:
- Publication type:
- Article
1096-P: Determining the Optimal Fasting Glucose Target for Patients with Type 2 Diabetes: Results of the FPG Goal Trial.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1096-P
- By:
- Publication type:
- Article
CNTNAP2 Protein Is Degraded by the Ubiquitin–Proteasome System and the Macroautophagy-Lysosome Pathway.
- Published in:
- Molecular Neurobiology, 2023, v. 60, n. 5, p. 2455, doi. 10.1007/s12035-023-03227-9
- By:
- Publication type:
- Article
Trehalose Inhibits Aβ Generation and Plaque Formation in Alzheimer's Disease.
- Published in:
- Molecular Neurobiology, 2020, v. 57, n. 7, p. 3150, doi. 10.1007/s12035-020-01942-1
- By:
- Publication type:
- Article
Ethanol Alters APP Processing and Aggravates Alzheimer-Associated Phenotypes.
- Published in:
- Molecular Neurobiology, 2018, v. 55, n. 6, p. 5006, doi. 10.1007/s12035-017-0703-3
- By:
- Publication type:
- Article
Traumatic Brain Injury Alters the Metabolism and Facilitates Alzheimer’s Disease in a Murine Model.
- Published in:
- Molecular Neurobiology, 2018, v. 55, n. 6, p. 4928, doi. 10.1007/s12035-017-0687-z
- By:
- Publication type:
- Article
A Novel Alzheimer-Associated SNP in <italic>Tmp21</italic> Increases Amyloidogenesis.
- Published in:
- Molecular Neurobiology, 2018, v. 55, n. 3, p. 1862, doi. 10.1007/s12035-017-0459-9
- By:
- Publication type:
- Article
Regulation of SET Gene Expression by NFkB.
- Published in:
- Molecular Neurobiology, 2017, v. 54, n. 6, p. 4477, doi. 10.1007/s12035-016-9967-2
- By:
- Publication type:
- Article
Upregulation of SET Expression by BACE1 and its Implications in Down Syndrome.
- Published in:
- Molecular Neurobiology, 2015, v. 51, n. 2, p. 781, doi. 10.1007/s12035-014-8782-x
- By:
- Publication type:
- Article
Hypoxia Signaling Regulates Macrophage Migration Inhibitory Factor (MIF) Expression in Stroke.
- Published in:
- Molecular Neurobiology, 2015, v. 51, n. 1, p. 155, doi. 10.1007/s12035-014-8727-4
- By:
- Publication type:
- Article
Aberrant Expression of RCAN1 in Alzheimer's Pathogenesis: A New Molecular Mechanism and a Novel Drug Target.
- Published in:
- Molecular Neurobiology, 2014, v. 50, n. 3, p. 1085, doi. 10.1007/s12035-014-8704-y
- By:
- Publication type:
- Article
Physiological clearance of tau in the periphery and its therapeutic potential for tauopathies.
- Published in:
- Acta Neuropathologica, 2018, v. 136, n. 4, p. 525, doi. 10.1007/s00401-018-1891-2
- By:
- Publication type:
- Article